Breaking News
0

Abeona Therapeutics Inc (ABEO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Abeona Therapeutics's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.320 +0.050    +2.20%
15/11 - Closed. Currency in USD ( Disclaimer )
Type: Equity
Market: United States
ISIN: US00289Y1073 
CUSIP: 00289Y107
  • Volume: 190,810
  • Bid/Ask: 2.120 / 2.400
  • Day's Range: 2.229 - 2.400
START TRADING NOW
| AD | 75% of retail investor accounts lose money when trading spread bets and CFDs with this provider
Abeona Therapeutics 2.320 +0.050 +2.20%
START TRADING NOW
| AD | 75% of retail investor accounts lose money when trading spread bets and CFDs with this provider

ABEO Overview

 
This is the main Abeona Therapeutics Inc stock chart and current price. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close2.27
Day's Range2.229 - 2.4
Revenue3M
Open2.28
52 wk Range1.46 - 9.55
EPS - 1.59
Volume190,810
Market Cap118.45M
Dividend (Yield)N/A (N/A)
Average Vol. (3m)978,384
P/E RatioN/A
Beta2.07
1-Year Change - 71.88%
Shares Outstanding51,054,395
Next Earnings DateMar 10, 2020
What is your sentiment on Abeona Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Abeona Therapeutics Inc News


Ultragenyx's Mepsevii OK'd in Europe for MPS VII
Ultragenyx's Mepsevii OK'd in Europe for MPS VII By Seeking Alpha - Aug 27, 2018

As expected, the European Commission approves Ultragenyx's Mepsevii (vestronidase alfa) for the treatment of non-neurological manifestations of mucopolysaccharidosis VII (MPS VII)...

Abeona Therapeutics Inc Analysis


Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Sell Strong Sell Strong Sell Strong Sell Sell
Technical Indicators Strong Sell Sell Sell Strong Sell Strong Sell
Summary Strong Sell Strong Sell Strong Sell Strong Sell Strong Sell

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Homing Pigeon 30 Current
Completed Patterns
Engulfing Bearish 30 1 Nov 15, 2019 03:00PM
Homing Pigeon 15 1 Nov 15, 2019 03:30PM
Engulfing Bearish 1M 6 May 19

Abeona Therapeutics Inc Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 2.320 2.120 2.400 190,810 +2.20% USD 15/11  
  Stuttgart 2.060 6.517 6.715 240 0.00% EUR 15/11  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Apple 265.76 265.78 263.01 +3.12 +1.19% 25.09M 15/11  
  Facebook 195.10 195.30 193.38 +1.95 +1.01% 11.53M 15/11  
  Alphabet A 1,333.54 1,333.54 1,311.89 +24.39 +1.86% 1.96M 15/11  
  Cypress Energy Partners LP 9.67 9.86 9.59 +0.28 +2.98% 20.50K 15/11  
  Microsoft 149.97 149.99 148.27 +1.91 +1.29% 23.51M 15/11  
  Tesla 352.17 352.80 348.36 +2.82 +0.81% 4.81M 15/11  
  IBM 134.40 135.12 134.03 +0.40 +0.30% 3.26M 15/11  
  CGG ADR 2.5800 2.6300 2.5600 +0.1100 +4.45% 8.32K 15/11  
  Twitter Inc 29.25 29.43 28.91 +0.36 +1.25% 12.17M 15/11  
  AMD 38.56 39.37 38.34 +0.21 +0.55% 63.02M 15/11  

Abeona Therapeutics Inc Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

83

Equity Type

ORD

Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company developing novel gene therapies for life-threatening rare genetic diseases. The Company’s lead programs include ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB). It is also developing ABO-101 (AAV-NAGLU) for Sanfilippo syndrome type B (MPS IIIB), ABO-201 (AAV-CLN3) gene therapy for juvenile Batten disease (JNCL), ABO-202 (AAV-CLN1) for treatment of infantile Batten disease (INCL), EB-201 for epidermolysis bullosa, ABO-301 (AAV-FANCC) for Fanconi anemia disorder and ABO-302 using a novel CRISPR/Cas9-based gene editing approach to gene therapy for rare blood diseases. The Company also has a plasma-based protein therapy pipeline, including alpha-1 protease inhibitor (SDF Alpha) for inherited COPD, using its proprietary Salt Diafiltration ethanol-free process.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States), Securities and Exchange Commission (United States) $0 Start Trading
National Futures Association (United States), Financial Industry Regulatory Authority (United States), Securities Investor Protection Corporation (United States) $500 Start Trading
Securities Investor Protection Corporation (United States) $0 Start Trading
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

ABEO Comments

Write your thoughts about Abeona Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
jiko jiko
jiko jiko Apr 10, 2018 1:02PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Great company, solid fundamentals and lots of potential.
Fl Fa
Fl Fa Apr 10, 2018 9:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
really... with huge deficit
MfB Iod
MfB Iod Apr 10, 2018 9:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Fl Fa where are you seeing the deficit?
Fl Fa
Fl Fa Apr 10, 2018 9:02AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
MfB Iodwhere are you seeing the solid fundamentals?
Teric Weasly
Teric Weasly Jan 31, 2018 7:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
jesus christ this is ***
Fl Fa
Fl Fa Jan 31, 2018 7:40PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
crap?..
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email